Most of the (slowly) growing number of staff from insurance incumbents now engaging with the InsurTech movement are understandably focused on what the ideas might do for their companies - whether as an enabler or a disruptor.  

As this article reminds us, for the innovator themselves, funding is as much an issue as the product itself.  Martyn outlines the need for more pre-seed VC funding (and how Forward Partners does this).

What role should we as the London Market be playing - via InsTech London, LM Innovation Exchange or some other route - to try and bring in more of this pre-seed VC support.

Answers on a postcard please.